Privacy preference
MEDtalks would like to keep you informed about the content that is most relevant to you. Click
here
for more information.
Yes
No
Back
ASH 2019: blinatumomab vs. chemotherapie post-reïnductie bij 1e relaps B-ALL
Chat with us
, powered by
LiveChat